Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule

• Published in: Vaccine Vol. 38; no. 7; pp. 1593 - 1596
• Main Authors: Galor, Inbal, Perry Markovich, Michal, Wolf, Dana, Haber, Meital, Hartal, Michael, Avramovich, Eva
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 11.02.2020; Elsevier Limited
• Subjects: Adolescent; Age; Allergy and Immunology; At risk populations; at-risk population; Birth; Childhood; Children; Female; Gender differences; Hepatitis; Hepatitis A; Hepatitis A - epidemiology; Hepatitis A - prevention & control; Hepatitis A Antibodies - blood; Hepatitis A vaccine; Hepatitis A Vaccines - administration & dosage; Hepatitis A virus; Hepatovirus A; Humans; immunity; inactivated vaccines; Israel; Israel - epidemiology; Laboratories; Male; Military Personnel; Military service; Population; Population studies; Risk groups; Schedules; Seroepidemiologic Studies; seroprevalence; Serosurvey; Vaccination; Vaccines; Vaccines, Inactivated; Viruses; Young Adult; Young adults; Israel; Serosurvey; Hepatitis A; Hepatitis A vaccine

Vaccine against Hepatitis A virus (HAV) is part of the routine vaccination schedule in Israel since 1999. As of 2016, new recruits to the Israel Defense Forces should have been vaccinated in their childhood. This sero-survey aimed to determine immunity against HAV 18 years after childhood vaccinatio...